イタリア - イタリア語 - myHealthbox

guna spa - serenoa repens - capsule - 40.5g - serenoa repens e vitamine - ipofertilità - integratore alimentare - spermotrend è indicato per aiutare a ridurre l’impatto negativo dello stress ossidativo sulla capacità riproduttiva maschile.

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

smartpractice denmark aps - test allergologici - test allergologici

欧州連合 - イタリア語 - EMA (European Medicines Agency)

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

欧州連合 - イタリア語 - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenti antineoplastici - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

ipsen s.p.a - lanreotide - lanreotide

欧州連合 - イタリア語 - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplasie al seno - agenti antineoplastici - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

sandoz spa - clozapina - compresse - "100mg" 28 compresse in blister pp/al

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

sandoz spa - clozapina - compresse - "25mg" 28 compresse in blister pp/al

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

astrazeneca spa - budesonide - capsule - "3 mg capsule rigide a rilascio modificato" 50 capsule

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

sandoz spa - paroxetina cloridrato - compresse rivestite - "20 mg compresse rivestite con film" 28 compresse in blister al/pvc